Why Should Food Businesses Consult a Consumer Fraud Attorney?

Express misrepresentation involves explicit false statements, such as claiming a product is organic when it is not certified, labeling a product gluten-free without meeting FDA standards, or stating a product contains a beneficial ingredient it does not contain. Implied misrepresentation is subtler: it may arise from selective disclosure, such as highlighting one ingredient while omitting a major allergen, or from imagery suggesting a product origin or composition it does not possess. Courts evaluate whether the net impression conveyed to a consumer would lead a reasonable person to believe something false about the product. This distinction matters because express claims are often easier for plaintiffs to establish, while implied misrepresentation requires the defendant to understand how consumers actually interpret the totality of the marketing message.

The FDA establishes labeling standards for food products, including ingredient disclosure requirements, allergen warnings, and nutrient content claims. State attorneys general and private litigants often use these federal standards as a baseline for consumer fraud claims. When a product violates FDA labeling rules, plaintiffs argue that the violation itself demonstrates the misrepresentation. However, compliance with FDA standards does not automatically shield a company from state consumer fraud liability if a court finds the label still misleads consumers despite technical compliance. This gap between regulatory compliance and litigation risk is where businesses most frequently encounter exposure.

When a company makes an error in labeling or fails to disclose a material fact, courts ask whether the company acted with knowledge of the falsity, reckless indifference to truth, or mere negligence. A company that conducts ingredient testing and discovers a discrepancy but continues to market the product with the old label faces stronger scienter findings than one that relied on supplier certifications without independent verification. From a practitioner's perspective, the difference between these scenarios can determine whether a case settles early or proceeds to discovery and trial. Documentation of quality control processes, supplier audits, and label review procedures becomes critical evidence in defending against scienter allegations.

Class action plaintiffs must establish that the misrepresentation affects a sufficiently large group of consumers and that common questions of law or fact predominate. In food fraud cases, courts often certify classes based on purchase of a specific product during a defined period. The injury calculation typically centers on the difference between what consumers paid and what they would have paid had they known the truth, or the value of the product as represented versus its actual value. Defendants may challenge class certification by arguing that individual reliance varies too widely or that damages cannot be calculated on a classwide basis.

New York state courts apply CPLR Article 9 for class actions and generally follow federal class action standards. Class certification decisions in New York federal courts (SDNY) may influence how state courts approach similar food fraud cases. A procedural risk arises when a defendant fails to preserve evidence of labeling practices, supplier communications, or quality control records before a class action is filed; courts may draw adverse inferences from missing documentation, effectively strengthening the plaintiff's case on scienter or liability. Early preservation and organization of records related to product formulation, testing, and label approval can materially affect litigation exposure.

In cases involving systematic misrepresentation across a product line or where a company concealed labeling errors to maintain sales, consumer fraud claims may intersect with accounting fraud allegations if the company's financial statements or investor disclosures misrepresented the scope of labeling defects or regulatory exposure. Similarly, if a company's systems were compromised and product information was altered without authorization, account takeover fraud principles may apply to the unauthorized access or data manipulation underlying the misrepresentation.

From a risk management perspective, food companies should maintain contemporaneous records of label design decisions, ingredient sourcing, testing protocols, and any internal communications identifying labeling concerns. When a company discovers a potential misrepresentation, the decision to disclose it, recall the product, or correct labeling should be made in consultation with counsel, as these actions create a record that may be discoverable in litigation. Proactive correction often reduces damages exposure, but the timing and scope of disclosure matter significantly in establishing whether the company acted with scienter or in good faith.